Literature DB >> 30856420

Historical trend toward improved long-term outcome in childhood absence epilepsy.

Elliot Morse1, Kathryn Giblin1, Mi Hae Chung1, Carolin Dohle1, Anne T Berg2, Hal Blumenfeld3.   

Abstract

We retrospectively analyzed published studies to investigate historical trends in outcome of childhood absence epilepsy (CAE). We included patients based on onset of absence seizures in childhood, 3 Hz bilateral spike-wave discharges on EEG, and availability of seizure-free outcome data. The primary endpoint was seizure-freedom off medications by study publication year. We also analyzed relationships between seizure-freedom and 1. treatment medication, and 2. CAE diagnostic criteria. We included 29 studies published 1945-2013, encompassing 2416 patients. Seizure-freedom off medications was higher for studies after 1985 versus before 1975 (82% versus 35%; p < 0.001). Ethosuximide and valproate were used more commonly after 1985, and patients previously treated with ethosuximide or valproate had higher seizure-freedom off medications than those treated only with other medications (64% versus 32%; χ2>10; p < 0.001). Although differences in diagnostic criteria for early vs. later studies did not reach statistical significance, later studies tended to use normal EEG background (p = 0.09) and absence of comorbid disorders (p = 0.09) as criteria more commonly. These findings demonstrate that seizure-freedom off medications has improved in published CAE studies after 1985. Our results are limited due to retrospective analysis. Further work is needed with prospective, controlled trials to establish factors leading to improved long-term prognosis in CAE.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Childhood absence epilepsy; Epileptogenesis; Ethosuximide; Prognosis; Valproate

Mesh:

Substances:

Year:  2019        PMID: 30856420      PMCID: PMC6573015          DOI: 10.1016/j.eplepsyres.2019.02.013

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  11 in total

1.  Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.

Authors:  Tracy A Glauser; Avital Cnaan; Shlomo Shinnar; Deborah G Hirtz; Dennis Dlugos; David Masur; Peggy O Clark; Peter C Adamson
Journal:  Epilepsia       Date:  2012-11-21       Impact factor: 5.864

2.  Early treatment suppresses the development of spike-wave epilepsy in a rat model.

Authors:  Hal Blumenfeld; Joshua P Klein; Ulrich Schridde; Matthew Vestal; Timothy Rice; Davender S Khera; Chhitij Bashyal; Kathryn Giblin; Crystal Paul-Laughinghouse; Frederick Wang; Anuradha Phadke; John Mission; Ravi K Agarwal; Dario J Englot; Joshua Motelow; Hrachya Nersesyan; Stephen G Waxman; April R Levin
Journal:  Epilepsia       Date:  2007-12-06       Impact factor: 5.864

3.  Long-term seizure remission in childhood absence epilepsy: might initial treatment matter?

Authors:  Anne T Berg; Susan R Levy; Francine M Testa; Hal Blumenfeld
Journal:  Epilepsia       Date:  2014-02-11       Impact factor: 5.864

4.  Long-term outcome of childhood absence epilepsy: Dutch Study of Epilepsy in Childhood.

Authors:  Petra M C Callenbach; Paul A D Bouma; Ada T Geerts; Willem Frans M Arts; Hans Stroink; Els A J Peeters; Cees A van Donselaar; A C Boudewijn Peters; Oebele F Brouwer
Journal:  Epilepsy Res       Date:  2009-01-04       Impact factor: 3.045

Review 5.  Diagnostic challenges in epilepsy: seizure under-reporting and seizure detection.

Authors:  Christian E Elger; Christian Hoppe
Journal:  Lancet Neurol       Date:  2018-03       Impact factor: 44.182

6.  Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy.

Authors:  Gabi Dezsi; Ezgi Ozturk; Davor Stanic; Kim L Powell; Hal Blumenfeld; Terence J O'Brien; Nigel C Jones
Journal:  Epilepsia       Date:  2013-03-06       Impact factor: 5.864

7.  Childhood absence epilepsy: behavioral, cognitive, and linguistic comorbidities.

Authors:  Rochelle Caplan; Prabha Siddarth; Lesley Stahl; Erin Lanphier; Pamela Vona; Suresh Gurbani; Susan Koh; Raman Sankar; W Donald Shields
Journal:  Epilepsia       Date:  2008-06-13       Impact factor: 5.864

8.  Anti-epileptogenesis: Electrophysiology, diffusion tensor imaging and behavior in a genetic absence model.

Authors:  Gilles van Luijtelaar; Asht M Mishra; Peter Edelbroek; Daniel Coman; Nikita Frankenmolen; Pauline Schaapsmeerders; Giulio Covolato; Nathan Danielson; Hannah Niermann; Kryzstof Janeczko; Anne Kiemeneij; Julija Burinov; Chhitij Bashyal; Madeline Coquillette; Annika Lüttjohann; Fahmeed Hyder; Hal Blumenfeld; Clementina M van Rijn
Journal:  Neurobiol Dis       Date:  2013-08-23       Impact factor: 5.996

9.  Impaired consciousness in patients with absence seizures investigated by functional MRI, EEG, and behavioural measures: a cross-sectional study.

Authors:  Jennifer N Guo; Robert Kim; Yu Chen; Michiro Negishi; Stephen Jhun; Sarah Weiss; Jun Hwan Ryu; Xiaoxiao Bai; Wendy Xiao; Erin Feeney; Jorge Rodriguez-Fernandez; Hetal Mistry; Vincenzo Crunelli; Michael J Crowley; Linda C Mayes; R Todd Constable; Hal Blumenfeld
Journal:  Lancet Neurol       Date:  2016-12       Impact factor: 44.182

10.  Pretreatment behavior and subsequent medication effects in childhood absence epilepsy.

Authors:  Ruth C Shinnar; Shlomo Shinnar; Avital Cnaan; Peggy Clark; Dennis Dlugos; Deborah G Hirtz; Fengming Hu; Chunyan Liu; David Masur; Erica F Weiss; Tracy A Glauser
Journal:  Neurology       Date:  2017-09-15       Impact factor: 9.910

View more
  1 in total

1.  Maladaptive myelination promotes generalized epilepsy progression.

Authors:  Juliet K Knowles; Haojun Xu; Caroline Soane; Ankita Batra; Tristan Saucedo; Eleanor Frost; Lydia T Tam; Danielle Fraga; Lijun Ni; Katlin Villar; Sydney Talmi; John R Huguenard; Michelle Monje
Journal:  Nat Neurosci       Date:  2022-05-02       Impact factor: 28.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.